21. Tony's Cancer Page - Non-Hodgkins Lymphoma (NHL) THIS WEBSITE HAS MOVED TO A NEW ADDRESS! Please change your favoritesor bookmarks to the following http//inspirezone.org/tonycan.htm. http://www.geocities.com/Heartland/Bluffs/7608/tonycan.htm

THIS WEBSITE HAS MOVED TO A NEW ADDRESS! Please change your favorites or bookmarks to the following: http://inspirezone.org/tonycan.htm

22. Tony's Cancer Page - Non-Hodgkins Lymphoma (NHL) A long term survivor (diagnosed 1988) of non-Hodgkin's Lymphoma describes his original symptoms, diagnosi Category Health Conditions and Diseases Lymphoma Personal Pages...... INTRODUCTION. The purpose of this page is to briefly report on my experiencewith Cancer (nonhodgkins lymphoma), which began in May of 1988. http://www.inspirezone.org/tonycan.htm

If you prefer no music, click the stop button! for the words to the music click HERE. Tony's Cancer Page The personal experience of a long-term survivor of non-Hodgkin's Lymphoma Updated February 11, 2003 INTRODUCTION The purpose of this page is to briefly report on my experience with Cancer (non-Hodgkins Lymphoma), which began in May of 1988. I hope that you will gain information, encouragement, and motivation. Cancer type - non-Hodgkin's Lymphoma (large cell)- Age at diagnosis- 42 BACKGROUND In 1988, I was a very active and healthy person.  I had spent my 42 years basically without any health problems.  No broken bones, no trips to the hospital for any reason, no doctor visits except for routine check-ups.  I lived a very healthy lifestyle, which involved running 5 to 10 miles daily and competing in weekend road races along with my wife Donna.  I had a very healthy diet consisting of a low-fat, high carbohydrate regimen.  I coached cross-country at the High School and each day, trained with my team and then ran with Donna when I got home from practice.  I thought that I was probably one of the healthiest people in Toccoa, Georgia.  That's when I started having problems. START OF PROBLEM FAMILY REACTION One of the toughest parts was telling my family.  I was doing fine at first but when I saw my Daddy cry, it broke me up.  My wife was a strong, loving, pillar of support throughout the ordeal and my Mom and Dad and my two brothers and their families were always there and more than willing to do anything that they could to help out.  I drew most of my strength from the prayers of my family and of my Church family and my extended Christian Family.  Early on, I turned the whole situation over to God who had sent Jesus to be my personal Savior.  I understood from the beginning that as a Christian, I was not promised that I would never have problems, but I was promised that He would never leave me or forsake me.

23. Information On Non-hodgkins Lymphoma Cancer And Radioimmunotherapy. Articles And hodgkins disease Targeted Information for Patients With nonhodgkins lymphoma. http://www.lymphomainnovations.com/lymphomainnovations/nhl.asp

About Us Contact Us Targeted Information for Patients With Non-Hodgkins Lymphoma Understanding Radioimmunotherapy Radioimmunotherapy and NHL Related Articles Related Links ... Home Supported through an unrestricted educational grant from IDEC Pharmaceuticals Click here for more information from our sponsor Radioimmunotherapy and NHL Starting Targeted Therapy For Lymphoma: What Are The Options? Targeted therapies, those that hone in on cancer cells, are the latest weapons used in the treatment of Non-Hodgkins lymphoma. Learn about the different targeted therapies available and how they are selected. watch program >> read transcript >> Radioimmunotherapy for Lymphoma: When Should It Be Used? Harnessing radiation to attack cancer cells is the hottest new therapy in lymphoma treatment. But doctors are still determining when is the best time to use radioimmunotherapy. Find out how this therapy fits into lymphoma treatment plans. watch program >> read transcript >>

24. Radioimmunotherapy For B Cell Non-Hodgkins Lymphoma Radioimmunotherapy for B Cell nonhodgkins lymphoma. IDEC PharmaceuticalsCorporation has announced the final results of two pivotal http://www.bloodline.net/stories/storyReader$2304

Bloodline Home About Call for Papers Free Membership ... Search Educational Features Image Atlas Case Studies Private Lectures Conference Reviews ... Glossary Resources Conference Calendar Hematology Links Full Text Journals Classifieds Specialties BMT/Stem Cell Cord Blood Thrombosis Hemostasis ... Veterinary News Hematology News BloodLink Newsletter Blood News Update Discussion Today's Discussion Create New Topic List by Topic Members Join Now Login Radioimmunotherapy for B Cell Non-Hodgkins Lymphoma IDEC Pharmaceuticals Corporation has announced the final results of two pivotal trials of Zevalin(TM) (Ibritumomab Tiuxetan), an investigational radioimmunotherapy, during oral presentations at the 42nd Annual Meeting of the American Society of Hematology (ASH). Thomas E. Witzig, M.D. of the Mayo Clinic, Rochester, MN, delivered an oral presentation of a Phase III randomized, controlled study of 143 patients with relapsed or refractory low grade, follicular, or CD20-positive transformed B-cell non-Hodgkins lymphoma (NHL). He noted that the Zevalin combined with Rituxan arm of the study showed an overall response rate (ORR) of 80 percent, compared to the Rituxan(R) (Rituxumab) alone control arm, which showed an overall response rate of 56 percent. A treatment course for Zevalin includes a Rituxan infusion (250 mg/m.2) on day one, followed by infusions of Rituxan (250 mg/m2) and Zevalin (at a standard radiation dose of 0.4 mCi/kg of patient body weight) on day eight. A treatment course of the Rituxan control consisted of four weekly doses of 375 mg/m2 of Rituxan.

25. NON-HODGKINS LYMPHOMA nonhodgkins lymphoma. JULY 2002 NON-HODGKINS'S LYMPHOMA. When I foundout my husband Jim had stage four, Non-Hodgkin's Lymphoma http://home.thirdage.com/friendship/dreamchaser22/lymphoma.html

NON-HODGKINS LYMPHOMA JULY 2002 NON-HODGKINS'S LYMPHOMA When I found out my husband Jim had stage four, Non-Hodgkin's Lymphoma cancer I realized that I could help myself, family and friends to understand the disease with an information page. WHAT IS LYMPHOMA? WHAT IS NON-HODGKIN'S LYMPHOMA? Your body contains white blood cells called "lymphocytes" that help protect against disease and infection. When these cells become cancerous, the result is called a lymphoma. Non-Hodgkin's lymphoma is one of two main types of lymphoma. The other type is called Hodgkin's disease or Hodgkin's lymphoma. When lymphoma cells begin to multiply they may form a tumor, a clump of cancer cells. They can also spread to other areas of the body. Lymphomas are usually found in the lymph modes or bone marrow. There may be more than 20 types of NHL. Usually, NHL is divided into three types: LOW-GRADE NHL...these are the slowest growing types of NHL. INTERMEDIATE-GRADE...these types of NHL grow quickly. HIGH-GRADE NHL...this includes the fastest, most aggressively growing NHL types. THERE ARE FOUR STAGES OF NHL: STAGE 1....the cancer is found in only one part of the body..single lymph node.

26. Non-Hodgkins Lymphoma - Published In AIDS, March 30, 2001 nonhodgkins lymphoma (PDF of entire published article attached) Thislarge study published in AIDS (2001 March 30; 15(5)629-633 http://www.natap.org/2001/may/nhl050601.htm

Non-Hodgkins Lymphoma PDF of entire published article attached) This large study published in AIDS (2001 March 30; 15(5):629-633) reports that both KS and NHL incidence have declined since June 1996 (the advent of HAART) but that the incidence of KS has declined more than NHL. Time period Incidence/1000 person-years (95% CI) KS July '94 -June '96 Jan '96 -Dec '98 NHL July '94 -June '96 June '96-Dec '98 Australian researchers report: This study finds decreasing incidence rates of both NHL and KS in people with HIV since the introduction of potent anti-retroviral therapies. For NHL, incidence had been increasing prior to 1996, and this increase masked the decrease since the introduction of the new HIV therapies when long-term trends were considered. The increase in NHL incidence in the early epidemic, which was also seen for KS, may have been related to increasing immune deficiency of the cohort. This study also confirms at a population level the previously described decreases in the incidence of KS during the 1990s. This decrease began before the introduction of the new therapies. KS has decreased in incidence by far more than NHL, so that NHL is now the most common AIDS-associated cancer in Australia. It is unclear why rates of NHL appear to be decreasing more slowly than other AIDS-associated illnesses, but there are at least three possible explanations. First, unlike KS, NHL does not appear to be due to a specific infective agent, so partial immune restoration may be less effective in prevention. Second, NHL occurs at a less severe degree of immune deficiency than most other AIDS-associated illnesses. Third, there is evidence that chronic stimulation of the immune system is a risk factor for AIDS-related NHL, and potent combination antiretroviral therapy may be only partially effective at reversing this immune stimulation [14,15]. (Editorial note from Jules Levin: does this make a case towards earlier treatment for HIV to avoid immune decline and active viral stimulation which treatment inhibitis? Perhaps this is one consideration among many. Also to be considered, is what's the risk of getting NHL whether therapy is started earlier or later?)

27. Idarubicin (IDA) For Older Non-Hodgkins Lymphoma Patients a timely medical meeting newsletter IDARUBICIN (IDA) FOR OLDER NONHODGKINSLYMPHOMA PATIENTS F.Cabanillas, MD, University of Texas http://www.meds.com/conrad/ash/cabanillas.html

Conrad Notes Index ASH Index a timely medical meeting newsletter IDARUBICIN (IDA) FOR OLDER NON-HODGKINS LYMPHOMA PATIENTS Adriamycin (ADRIA) with low dose IDA in a complex regimen showed less myelosupression and lethal toxicity. Please see US package inserts on idarubicin ( Idamycin ) and doxorubicin ( Adriamycin Background on IDA and ADRIA As anthracyclines, both drugs produce cytotoxicity by binding to nucleic acids, interfering with nucleotide replication, and by blocking DNA and RNA polymerases. The cytocidal activity may be due to interaction with the enzyme topoisomerase II resulting in DNA-cleavable complexes. IDA is more lipophilic, penetrates cells faster, and is superior to ADRIA in treating acute myeloid leukemia (AML). Patient selection Cabanillas and coworkers entered 156 APPNHL patients presenting an unfavorable tumor score predictive of a 3-year survival rate of 28% using standard CHOP therapy. (CHOP is the acronym for a regimen of cyclophosphamide, ADRIA, vincristine, and prednisone.) Fifty-two (37%) of the 142 evaluable patients were >60 years old and at increased risk. In view of the patients' poor prognosis, all received a complex regimen as basic treatment. One group of patients had low-dose IDA instead of ADRIA according to random assignment. The basic regimen, called ATT, consisted of Solu-Medrol

28. Frequently Asked Questions About Non-Hodgkins Lymphoma Frequently Asked Questions About NonHodgkin's Lymphoma Information from TheJames Cancer Hospital and Solove Research Institute. lymphoblastic lymphoma. http://www.jamesline.com/output/content/cainfo/nhodhome/nhodfaq.htm

Frequently Asked Questions About Non-Hodgkin's Lymphoma Information from The James Cancer Hospital and Solove Research Institute 1. What are Non-Hodgkin's Lymphomas? ANSWER: Lymphoma is a general term for cancers that develop in the lymphatic system. The most common type is called Hodgkin's. All other Lymphomas are grouped together and are called non-Hodgkin's lymphomas. The lymphatic system is part of the body's immune defense system. Its job is to help fight diseases and infection. The lymphatic system includes a network of thin tubes that branch, like blood vessels, into tissues throughout the body. Lymphatic vessels carry lymph, a colorless, watery fluid that contains infection-fighting cells called lymphocytes. Along this network of vessels are small, bean-shaped organs called lymph nodes. Clusters of lymph nodes are found in the underarms, groin, neck, chest, and abdomen. Other parts of the lymphatic system are the spleen, thymus, tonsils, and bone marrow. Lymphatic tissue is also found in other parts of the body, including the stomach, intestines, and skin. Like all types of cancer, lymphomas are diseases of the body's cells. Healthy cells grow, divide, and replace themselves in an orderly manner. This process keeps the body in good repair.

29. Lymphoma – Non-Hodgkins Trial to Evaluate Preliminary Safety Efficacy of Hu1D10 in Patients w Relapsedor Refractory Grades I, II, or III BCell non-hodgkins lymphoma (inc Follicular http://www.jamesline.com/output/content/CCCsite/ccc/Protocols/nhod.htm

Lymphoma – Non-Hodgkins Type of Protocol IRB Consent Description Contact Name and Number CALGB 109901 Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma with Allogeneic Donor Stem Cells For more information, please contact The James Line at 1-800-293-5066 or email at cancerinfo@jamesline.com CALGB 50103 Phase II Study of Dose-Adjusted Epoch-Rituximab (EPOCH-R) Chemotherapy for Patients with Previously Untreated Aggressive CD20+ B-Cell Non-Hodgkin's Lymphoma (NHL) Histo documented Stage II, III or IV NHL w no evid of indolent lymphoma. No prior chemo. No known CNS involvement. For more information, please contact The James Line at 1-800-293-5066 or email at cancerinfo@jamesline.com CALGB 59901 A Phase II Study of 506U78 (IND#52611) in Patients with Previously Systemically Untreated Cutaneous T-Cell Lymphoma (CTCL) or with Refractory/Relapsed Non-Cutaneous Peripheral T-Cell Lymphoma (PTCL) For more information, please contact The James Line at 1-800-293-5066 or email at

30. U-M CCC - Information Guide - Non-Hodgkins Lymphoma Updated 11/2002. nonhodgkins lymphoma Information Guide. The purposeof this information guide is to help patients newly diagnosed http://www.cancer.med.umich.edu/learn/pwnonhodlymphoma.htm

Patient Education Resource Center Print-friendly version of this guide Show me other Information Guides (also known as PERC Pathways) Updated 11/2002 Non-Hodgkins Lymphoma Information Guide The purpose of this information guide is to help patients newly diagnosed with Non-Hodgkin's Lymphoma and their families find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center of the University of Michigan Comprehensive Cancer Center in room B1-361. Reference Available in the Patient Education Resource Center on level B-1 Lymphoma Research Foundation. Lymphoma Resource Guide . Full-text available online at the Patient Education section of the Lymphoma Research Foundation web site Pamphlets - Available in the Patient Education Resource Center on Level B-1 Lymphoma Research Foundation.

31. My Experience Of Non-Hodgkins Lymphoma Reviews, Ratings, Guide - Advice And Onli Home Lifestyle Health Problems My Experience of nonhodgkins lymphoma. MyExperience of non-hodgkins lymphoma, dooyoo user rating 0% recommendation, http://www.dooyoo.co.uk/lifestyle/health_problems/my_experience_of_non_hodgkins_

var mengo= rand(26000)-1; document.write('') register log in quick tour help ... more... deals community The best product Independent reviews and rankings The best price ... write reviews Search... Home Lifestyle Health Problems My Experience of Non-Hodgkins Lymphoma Products Reviews Users only Lifestyle only Health Problems My Experience of Non-Hodgkins Lymphoma dooyoo user rating recommendation var ebaylabel_quot = 'My Experience of Non-Hodgkins Lymphoma'; var ebaylabel = escape(ebaylabel_quot.replace(/"/g,'')); var ebaylink = 'http://www.dooyoo.co.uk/cya.jsp?dooyoopartnerID=0002&url=http://adfarm.mediaplex.com/ad/ck/710-3024-3218-3?MfcISAPICommand=GetResult%26query='+ebaylabel+'%26ebaytag1code=3%26ebaytag1ebayctry%26maxRecordsReturned=300%26maxRecordsPerPage=50%26SortProperty=MetaEndSort%26srchdesc=y'; document.write(''); Short Description Please only write here of you have had a direct experience of this condition overview reviews resources Buy one James Bond DVD for £15.99 and get one free! Here's your chance to complete your James Bond film collection - own all 18 titles for under £150! James Bond DVD Box set - only £169.99

32. Non-Hodgkins Lymphoma In General Reviews, Ratings, Guide - Advice And Online Sho Search Home Lifestyle Health Problems nonhodgkins lymphoma in general. Non-HodgkinsLymphoma in general, Be the first to rate this item! http://www.dooyoo.co.uk/lifestyle/health_problems/non_hodgkins_lymphoma_in_gener

var mengo= rand(26000)-1; document.write('') register log in quick tour help ... more... deals community The best product Independent reviews and rankings The best price ... write reviews Search... Home Lifestyle Health Problems Non-Hodgkins Lymphoma in general Products Reviews Users only Lifestyle only Health Problems Non-Hodgkins Lymphoma in general Be the first to rate this item! var ebaylabel_quot = 'Non-Hodgkins Lymphoma in general'; var ebaylabel = escape(ebaylabel_quot.replace(/"/g,'')); var ebaylink = 'http://www.dooyoo.co.uk/cya.jsp?dooyoopartnerID=0002&url=http://adfarm.mediaplex.com/ad/ck/710-3024-3218-3?MfcISAPICommand=GetResult%26query='+ebaylabel+'%26ebaytag1code=3%26ebaytag1ebayctry%26maxRecordsReturned=300%26maxRecordsPerPage=50%26SortProperty=MetaEndSort%26srchdesc=y'; document.write(''); Short Description Lymphoma is a general term for cancers that develop in the lymphatic system. They account for about 5 percent of all cases of cancer in this country. One type of lymphoma is called Hodgkin's disease. All other lymphomas are grouped together and are called non-Hodgkin's lymphomas. This refers to any group of cancers of lymphoid tissue that multiply unchecked. These are found mainly in the lymph nodes and spleen. Non-Hodgkin's lymphomas vary in their malignancy according to the activity of the abnormal cells. Primitive cells, or those that are poorly specialized, are most malignant. They tend to take over the lymph nodes rapidly overview reviews resources Buy one James Bond DVD for £15.99 and get one free!

33. Non-Hodgkins Lymphoma --- HealthandAge nonhodgkins lymphoma. non-hodgkins lymphoma. January 8, 2002. Question.My sister has non-Hodgkin's lymphoma that has just recurred after 7 years. http://www.healthandage.com/Home/gid7=61

English site German site March 31, 2003 Home Health Centers HealthandAge Network News ... Primer on Aging Choose Font Size Normal Large Extra Large Non-Hodgkins Lymphoma Non-Hodgkins Lymphoma January 8, 2002 Question My sister has non-Hodgkin's lymphoma that has just recurred after 7 years. I would like more information on this. Answer Non-Hodgkin's lymphoma is a type of malignancy (cancer) that affects cells involved in the immune system and that mostly reside in the lymph nodes. Non-Hodgkin's lymphoma is not a single disease but a collection of numerous types of lymphoma with greatly divergent clinical presentations, prognoses, and treatments. The current classification scheme for these includes over 20 sorts. Given this broad spectrum of diseases under the general classification of non-Hodgkin's lymphoma, a complete answer to your request for information about the significance of a recurrence is not possible. For those types of non-Hodgkin's lymphoma generally referred to as "indolent" (e.g., follicular small cell, low grade), recurrences are expected, and treatment is aimed at relief of symptoms rather than prolongation of life. In contrast, in diffuse B-cell lymphoma (an intermediate grade lymphoma), treatment aimed at cure is feasible. A number of new treatments have recently been developed for several different types of lymphoma and more are being investigated. In summary, the type of non-Hodgkin's lymphoma is very important to further discuss the likelihood of recurrence. Please see the link below.

34. Non-Hodgkins Lymphoma --- HealthandAge nonhodgkins lymphoma. News RELATED QUESTION . Non-HodgkinsLymphoma. January 8, 2002. Question. My sister has non-Hodgkin's http://www.healthandage.com/Home/gm=1!gid7=61

English site German site March 31, 2003 Home Health Centers HealthandAge Network News ... Primer on Aging Choose Font Size Normal Large Extra Large Non-Hodgkins Lymphoma News NON-HODGKIN'S LYMPHOMA Non-Hodgkins Lymphoma January 8, 2002 Question My sister has non-Hodgkin's lymphoma that has just recurred after 7 years. I would like more information on this. Answer Non-Hodgkin's lymphoma is a type of malignancy (cancer) that affects cells involved in the immune system and that mostly reside in the lymph nodes. Non-Hodgkin's lymphoma is not a single disease but a collection of numerous types of lymphoma with greatly divergent clinical presentations, prognoses, and treatments. The current classification scheme for these includes over 20 sorts. Given this broad spectrum of diseases under the general classification of non-Hodgkin's lymphoma, a complete answer to your request for information about the significance of a recurrence is not possible. For those types of non-Hodgkin's lymphoma generally referred to as "indolent" (e.g., follicular small cell, low grade), recurrences are expected, and treatment is aimed at relief of symptoms rather than prolongation of life. In contrast, in diffuse B-cell lymphoma (an intermediate grade lymphoma), treatment aimed at cure is feasible. A number of new treatments have recently been developed for several different types of lymphoma and more are being investigated. In summary, the type of non-Hodgkin's lymphoma is very important to further discuss the likelihood of recurrence. Please see the link below.

35. AEGiS-MMWR: Diffuse, Undifferentiated Non-Hodgkins Lymphoma Among Homosexual Mal Click here to return to CDC MMWR main menu Diffuse, Undifferentiatednonhodgkins lymphoma among Homosexual Males United States http://www.aegis.com/pubs/mmwr/1982/MM3121.html

Important note: Information in this article was accurate in June 1982. The state of the art may have changed since the publication date. Diffuse, Undifferentiated Non-Hodgkins Lymphoma among Homosexual Males United States MMWR Weekly, June 04, 1982 / 31(21);277-9 Centers for Disease Control and Prevention Patient 1: A 28-year-old hospital clerk complained of back and shoulder pain starting in early March 1981. Within a few days he had swelling of the right eye and an unsteady gait, and he was hospitalized on March 21. "Shotty" peripheral lymphadenopathy was present. A biopsy of an orbital mass and an enlarged cervical lymph node disclosed DUNHL. A myelogram revealed a T4-T6 block by an extradural mass. Radiation and chemotherapy led to complete remission. In September 1981, another tumor in the spinal cord was treated with radiation. The ensuing remission was temporary, and the patient died with disseminated DUNHL on January 15, 1982. Patient 2: A 33-year-old nurse developed a tumor in his left lower jaw in October 1981. Penicillin was given for a suspected abscess, but the mass enlarged. A biopsy on November 24 disclosed DUNHL. Tumor cells contained surface IgM, kappa type, indicating a B-cell tumor. The tumor involved a left axillary lymph node, the retroperitoneum, the bone marrow, and the meninges. Generalized "reactive" lymphadenopathy and mild splenomegaly were present. Systemic and intrathecal chemotherapy led to temporary tumor regression; the patient relapsed and died in March 1982.

36. Non-Hodgkins Lymphoma nonhodgkins lymphoma. http://gucfm.georgetown.edu/welchjj/netscut/heme_onc/NHL.html

Non-Hodgkins Lymphoma Lymphomas Heme-Onc Net Scut Home Please direct all comments to: Jack Welch, M.D., Ph.D. Last modification: April 30, 1999

37. Primary Non-Hodgkins Lymphoma Of The Breast. Abstract number 466P. Citation Annals of Oncology, Vol 11, Suppl.4October 2000, page 103 Primary nonhodgkins lymphoma of the breast. http://www.esmo.org/reference/abstracts00/lym/466.htm

Home Forgotten Password Site Updates ... Corner Abstract number: 466P Citation: Annals of Oncology, Vol 11, Suppl.4 October 2000, page 103 Primary non-Hodgkins lymphoma of the breast. Department of Medical Oncology, Radiotherapy and Epidemiology, Portuguese Institute of Medical Oncology, Porto, Portugal Introduction: Primary non-Hodgkins lymphoma (PNHL) is the most frequent hematopoietic tumour of the breast. About 2% of the extranodal lymphomas involve the breast as the primary site. The vast majority of lymphomas of the breast are of B cell lineage. Objective/Methods: We performed a retrospective study of the cases with PNHL admitted in our Institution between 1/1974 and 12/1999. Clinical data was reviewed. Overall (OS) and disease-free (DFS) survival curves were estimated by the method of Kaplan-Meier. Results: Non Hodgkin's lymphoma, extranodal About ESMO Education Annals of ... Patient Information ESMO Head Office, Via la Santa 7, 6962 Viganello-Lugano, Switzerland Tel. ++41 (0)91 973 1900, Fax ++41 (0)91 973 1902 Last Revised : 20 April 2001 Web Weaving™ By InfoStreet, Inc.

38. Clinico-pathologic Characteristics Of Non-Hodgkins Lymphoma Patients At Single C page 102 Clinicopathologic characteristics of non-hodgkins lymphomapatients at single centre in Central Anatolia. Ali Unal, Bülent http://www.esmo.org/reference/abstracts00/lym/459.htm

Home Forgotten Password Site Updates ... Corner Abstract number: 459P Citation: Annals of Oncology, Vol 11, Suppl.4 October 2000, page 102 Clinico-pathologic characteristics of non-Hodgkins lymphoma patients at single centre in Central Anatolia. Hematology, Erciyes University Medical School, Kayseri, Turkey Conclusion: In our patients; the rate of extra nodal (particularly gastrointestinal) involvement was lower than western countries, but the median age and male to female ratio of the patients were similar. Non Hodgkin's lymphoma, extranodal Non Hodgkin's lymphoma, pathology About ESMO Education Annals of ... Patient Information ESMO Head Office, Via la Santa 7, 6962 Viganello-Lugano, Switzerland Tel. ++41 (0)91 973 1900, Fax ++41 (0)91 973 1902 Last Revised : 20 April 2001 Web Weaving™ By InfoStreet, Inc. Top

39. UConn Health Center: News: Non-Hodgkins Lymphoma Promising New Treatment for nonHodgkin’s Lymphoma Offered by UConnHealth Center. UConn Health Center’s Division of Nuclear http://health.uchc.edu/news/zevalin.htm

What's New UConn House Call Promising New Treatment for non-Hodgkin’s Lymphoma Offered by UConn Health Center UConn Health Center’s Division of Nuclear Medicine clinicians are among the first in Connecticut to use an innovative and promising new treatment for non-Hodgkin’s lymphoma, a frequently occurring cancer of the lymph system. The treatment, developed by scientists and doctors after more than a decade of work, successfully uses the chemical attraction of antibody to antigen to deliver radiation to specific cancer cells. An antigen is a protein on the surface of a cell that makes antibodies react when an immune system response is required. With that biological process in mind, the researchers engineered an antibody that binds to the CD-20 receptor cell typically present in non-Hodgkin’s lymphoma. The antibody, which was recently approved by the Food and Drug Administration, is known as Zevalin. “The data from the Zevalin clinical trials shows tumor shrinkage and improvement in the quality of life for 80 percent of the patients,” said Ronald Weiner, Ph.D., an associate professor, Department of Diagnostic Imaging and Therapeutics and one of the researchers doing the investigation. Patients with low-grade, non-Hodgkin’s lymphoma typically have responded positively to radiation therapy. But that therapy is imprecise and can cause damage or even kill normal cells in the areas of the cancer being treated. Using the cancer-cell specific antibody, however, physicians can attach a minimal dose of radioactive isotope to it. It is a more precise treatment than radiation therapy and so less likely to harm nearby normal cells.

40. Non-Hodgkins Lymphoma More Important Cause Of AIDS July 24, 2000. nonhodgkins lymphoma more important causeof AIDS By By EMMA ROS AP Medical Writer AIDS Focus. http://www.canoe.ca/Health0007/24_aids.html

Inside CANOE.CA SLAM! Sports Jam! Showbiz AllPop CNEWS Webfin Money C-Health Lifewise AUTONET.CA Newsstand Travel Search eBay.ca Get away today 411 online Free E-Mail Shop.canoe.ca CareerConnection Classified Extra Match Contact Obituaries Today Restaurants Hotels Weather Horoscopes Lotteries Crossword Scoreboard News Ticker Biz Ticker Sports Ticker TV Listings Movie Listings CLIVE Concerts Mutual Funds Stocks Feedback Index Home Top Stories Health Topics Health Assoc. ... Forums TOOLS: Disease Database Drug Database Alt. Health Dictionary ... Encyclopedia July 24, 2000 Non-Hodgkins lymphoma more important cause of AIDS By By EMMA ROS AP Medical Writer AIDS Focus Cdn. AIDS Society New Face of AIDS Women and AIDS Preventing infection Gay Men and AIDS ... AIDS Chat Articles and Videos: LONDON While new medicines have dramatically reduced the chances of HIV patients developing AIDS , a new study indicates the percentage who contract non-Hodgkins lymphoma has quadrupled since the drugs were introduced six years ago. People infected with HIV are defined as having AIDS when their immune systems become so weak that they get one of 26 illnesses, including non-Hodgkins lymphoma, as well as pneumonia, brain infections and some other cancers. Experts have known that the effectiveness of the new combination drug therapy, called highly active antiretrovirals, varies depending on which of the 26 AIDS-defining illnesses are involved. Some experts have reported suspicions the new therapy doesn't work as well for non-Hodgkins lymphoma as for the other diseases.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 2     21-40 of 96    Back | 1  | 2  | 3  | 4  | 5  | Next 20